A single amphetamine infusion reverses deficits in dopamine nerve-terminal function caused by a history of cocaine self-administration

Neuropsychopharmacology

Volumn 40, Issue 8, 2015, Pages 1826-1836

  Ferris, Mark J ^a   Calipari, Erin S ^a   Rose, Jamie H ^a   Siciliano, Cody A ^a   Sun, Haiguo ^a   Chen, Rong ^a   Jones, Sara R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG EFFICACY; DRUG INFUSION; DRUG SELF ADMINISTRATION; IN VIVO STUDY; KINETICS; MALE; MOTIVATION; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTITUTION THERAPY; UNITED STATES; ANIMAL; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECTS; ELECTROSTIMULATION; IN VITRO STUDY; INSTRUMENTAL CONDITIONING; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; SPRAGUE DAWLEY RAT; TIME FACTOR;

AMPHETAMINE; ANIMALS; COCAINE; CONDITIONING, OPERANT; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; IN VITRO TECHNIQUES; INFUSIONS, INTRAVENOUS; MALE; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; TIME FACTORS;

EID: 84930824231     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.45     Document Type: Article

References (60)

1. Ahmed SH, Koob GF (1998). Transition from moderate to excessive drug intake: change in hedonic set point. Science 282: 298-300.
2. Ahmed SH, Lin D, Koob GF, Parsons LH (2003). Escalation of cocaine self-administration does not depend on altered cocaineinduced nucleus accumbens dopamine levels. J Neurochem 86: 102-113.
3. Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, Raniszewska K et al (2008). The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11: 780-789.
4. Boudanova E, Navaroli DA, Melikian HE (2008). Amphetamineinduced decreases in dopamine transporter surface expression are protein kinase C-independent. Neuropharmacology 54: 605-612.
5. Calipari ES, Ferris MJ, Zimmer BA, Roberts DCS, Jones SR (2013a). Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter. Neuropsychopharmacology 38: 2385-2392.
6. Calipari ES, Ferris MJ, Salahpour A, Caron MG, Jones SR (2013b). Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression. Nat Commun 4: 2720.
7. Calipari ES, Ferris MJ, Jones SR (2014a). Extended access of cocaine self-administration results in tolerance to the dopamine-elevating and locomotor-stimulating effects of cocaine. J Neurochem 128: 224-232.
8. Calipari ES, Ferris MJ, Melchior JR, Bermejo K, Salahpour A, Roberts DCS et al (2014b). Methylphenidate and cocaine selfadministration produce distinct dopamine terminal alterations. Addict Biol 19: 145-155.
9. Calipari ES, Sun HG, Eldeeb K, Luessen DJ, Feng X, Howlett AC et al (2014c). Amphetamine self-administration attenuates dopamine D2 autoreceptor function. Neuropsychopharmacology 39: 1833-1842.
10. Chen NH, Reith MEA (2007). Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells. J Neurochem 101: 377-388.
11. Chen NH, Reith MEA (2008). Substrates dissociate dopamine transporter oligomers. J Neurochem 105: 910-920.
12. Chen R, Tilley MR, Wei H, Zhou FW, Zhou FM, Ching S et al (2006). Abolished cocaine reward in mice with a cocaineinsensitive dopamine transporter. Proc Natl Acad Sci USA 103: 9333-9338.
13. Chiodo KA, Lack CM, Roberts DCS (2008). Cocaine selfadministration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats. Psychopharmacology 200: 465-473.
14. Czoty PW, Martelle JL, Nader MA (2010). Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys. Psychopharmacology 209: 375-382.
15. Czoty PW, Gould RW, Martelle JL, Nader MA (2011). Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys. Neuropsychopharmacology 36: 539-547.
16. Egana LA, Cuevas RA, Baust TB, Parra LA, Leak RK, Hochendoner S et al (2009). Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3. J Neurosci 29: 4592-4604.
17. Ferris MJ, Mateo Y, Roberts DCS, Jones SR (2011). Cocaineinsensitive dopamine transporters with intact substrate transport produced by self-administration. Biol Psychiatry 69: 201-207.
18. Ferris MJ, Calipari ES, Mateo Y, Melchior JR, Roberts DCS, Jones SR (2012). Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate. Neuropsychopharmacology 37: 1708-1716.
19. FerrisMJ, Calipari ES, Melchior JR, RobertsDCS, Espana RA, Jones SR (2013a). Paradoxical tolerance to cocaine after initial supersensitivity in drug-use-prone animals. Eur J Neurosci 38: 2628-2636.
20. Ferris MJ, Calipari ES, Yorgason JT, Jones SR (2013b). Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices. ACS Chem Neurosci 4: 693-703.
21. Ferris MJ, Espana RA, Locke JL, Konstantopoulos JK, Rose JH, Chen R et al (2014). Dopamine transporters govern diurnal variation in extracellular dopamine tone. Proc Natl Acad Sci USA 111: E2751-E2759.
22. Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR (1997). Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 282: 834-838.
23. Fleckenstein AE, Haughey HM, Metzger RR, Kokoshka JM, Riddle EL, Hanson JE et al (1999). Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur J Pharmacol 382: 45-49.
24. Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D et al (2001). Dextroamphetamine for cocainedependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 21: 522-526.
25. Grabowski J, Shearer J, Merrill J, Negus SS (2004a). Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29: 1439-1464.
26. Grabowski J, Rhoades H, Stotts A, Cowan K, Kopecky C, Dougherty A et al (2004b). Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two doubleblind randomized clinical trials. Neuropsychopharmacology 29: 969-981.
27. Hong WMC, Amara SG (2013). Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine-or PKC-regulated endocytosis in dopamine neurons. FASEB J 27: 2995-3007.
28. Letchworth SR, Nader MA, Smith HR, Friedman DP, Porrino LJ (2001). Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci 21: 2799-2807.
29. Little KY, Kirkman JA, Carroll FI, Clark TB, Duncan GE (1993). Cocaine use increases [H-3] Win-35428 binding-sites in human striatum. Brain Res 628: 17-25.
30. Malison RT, Best SE, van Dyck CH, McCance EF, Wallace EA, Laruelle M et al (1998). Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [I-123]beta-CIT SPECT. Am J Psychiatry 155: 832-834.
31. Malison RT, Mechanic KY, Klummp H, Baldwin RM, Kosten TR, Seibyl JP et al (1999). Reduced amphetamine-stimulated dopamine release in cocaine addicts as measured by [I-123] IBZM SPECT. J Nucl Med 40: 110P.
32. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A et al (2007). Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to selfadminister cocaine. Am J Psychiatry 164: 622-629.
33. Mateo Y, Lack CM, Morgan D, Roberts DCS, Jones SR (2005). Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharmacology 30: 1455-1463.
34. Narendran R, Martinez D (2008). Cocaine abuse and sensitization of striatal dopamine transmission: A critical review of the preclinical and clinical imaging literature. Synapse 62: 851-869.
35. Negus SS, Mello NK (2003a). Effects of chronic d-amphetamine treatment on cocaine-and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology 167: 324-332.
36. Negus SS, Mello NK (2003b). Effects of chronic d-amphetamine treatment on cocaine-and food-maintained responding under a second-order schedule in rhesus. Drug Alcohol Dependence 70: 39-52.
37. Negus SS (2003). Rapid assessment of choice between cocaine and food in rhesus monkeys: Effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology 28: 919-931.
38. Norman AB, Tabet MR, Norman MK, Tsibulksy VL (2014). Maintained cocaine self-administration is determined by quantal responses: implications for the measurement of antagonist potency. J Pharmacol Exp Ther 348: 311-315.
39. Oleson EB, Talluri S, Childers SR, Smith JE, Roberts DCS, Bonin KD et al (2009). Dopamine uptake changes associated with cocaine self-administration. Neuropsychopharmacology 34: 1174-1184.
40. O'Neill B, Tilley MR, Han DD, Thirtamara-Rajamani K, Hill ER, Bishop GA et al (2014). Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum. Neuropharmacology 79: 626-633.
41. Richards TL, Zahniser NR (2009). Rapid substrate-induced downregulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens. J Neurochem 108: 1575-1584.
42. Richardson NR, Roberts DCS (1996). Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66: 1-11.
43. Rothman RB, Blough BE, Baumann MH (2006). Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction. Trends Pharmacol Sci 27: 612-618.
44. Rothman RB, Blough BE, Baumann MH (2008). Dopamine/serotonin releasers as medications for stimulant addictions. Prog Brain Res 172: 385-406.
45. Rush CR, Stoops WW (2012). Agonist replacement therapy for cocaine dependence: a translational review. Future Med Chem 4: 245-265.
46. Saunders C, Ferrer JV, Shi L, Chen JY, Merrill G, Lamb ME et al (2000). Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocainesensitive mechanism. Proc Natl Acad Sci USA 97: 6850-6855.
47. Sitte HH, Farhan H, Javitch JA (2004). Oligomerization as a determinant of transporter function and trafficking. Mol Interv 4: 38-47.
48. Substance Abuse and Mental Health Services Administration (SAMHSA) (2008). National Survey on Drug Use and Health Available at http://oas. samhsa. gov/nhsda. htm.
49. Suto N, Ecke LE, Wise RA (2009). Control of within-binge cocaineseeking by dopamine and glutamate in the core of nucleus accumbens. Psychopharmacology 205: 431-439.
50. Suto N, Wise RA (2011). Satiating Effects of Cocaine Are Controlled by Dopamine Actions in the Nucleus Accumbens Core. J Neurosci 31: 17917-17922.
51. Tilley MR, O'Neill B, Han DD, Gu HH (2009). Cocaine does not produce reward in absence of dopamine transporter inhibition. Neuroreport 20: 9-12.
52. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Gatley SJ et al (1996a). Cocaine uptake is decreased in the brain of detoxified cocaine abusers. Neuropsychopharmacology 14: 159-168.
53. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Ding YS, Logan J et al (1996b). Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci USA 93: 10388-10392.
54. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R et al (1997). Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830-833.
55. Willuhn I, Burgeno LM, Groblewski PA, Phillips PEM (2014). Excessive cocaine use results from decreased phasic dopamine signaling in the striatum. Nat Neurosci 17: 704-709.
56. Yorgason JT, Espana RA, Jones SR (2011). Demon Voltammetry and Analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202: 158-164.
57. Zernig G, Ahmed SH, Cardinal RN, Morgan D, Acquas E, Foltin RW et al (2007). Explaining the escalation of drug use in substance dependence: models and appropriate laboratory tests. Pharmacology 80: 65-119.
58. Zimmer BA, Dobrin CV, Roberts DCS (2011). Brain-cocaine concentrations determine the dose self-administered by rats on a novel behaviorally dependent dosing schedule. Neuropsychopharmacology 36: 2741-2749.
59. Zimmer BA, Dobrin CV, Roberts DCS (2013). Examination of behavioral strategies regulating cocaine intake in rats. Psychopharmacology 225: 935-944.
60. Zimmer BA, Chiodo KA, Roberts DCS (2014). Reduction of the reinforcing effectiveness of cocaine by continuous D-amphetamine treatment in rats: importance of active self-administration during treatment period. Psychopharmacology 231: 949-954.